RT Journal Article
SR Electronic
T1 SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.20.20158329
DO 10.1101/2020.07.20.20158329
A1 Brant-Zawadzki, Michael
A1 Fridman, Deborah
A1 Robinson, Philip A.
A1 Zahn, Matthew
A1 German, Randy
A1 Breit, Marcus
A1 Hara, Junko
YR 2020
UL http://medrxiv.org/content/early/2020/07/25/2020.07.20.20158329.abstract
AB SARS-CoV-2 has driven a pandemic crisis. Serological surveys have been conducted to establish prevalence for covid-19 antibody in various cohorts and communities. However, the prevalence among healthcare workers is still being analyzed. The present study reports on initial sero-surveillance conducted on healthcare workers at a regional hospital system in Orange County, California, during May and June, 2020.Study participants were recruited from the entire hospital employee workforce and the independent medical staff. Data were collected for job title, location, covid-19 symptoms, a PCR test history, travel record since January 2020, and existence of household contacts with covid-19. A blood sample was collected from each subject for serum analysis for IgG antibodies to SARS- CoV-2.Of 3,013 tested individuals, a total 2,932 were included in the analysis due to some missing data. Observed prevalence of 1.06% (31 antibody positive cases), adjusted prevalence of 1.13% for test sensitivity and specificity were identified. Significant group differences between positive vs. negative were observed for age (z = 2.65, p = .008), race (p = .037), presence of fever (p < .001) and loss of smell (p < .001).Possible explanation for this low prevalence includes a relatively low local geographic community prevalence (∼4.4%) at the time of testing, the hospital’s timely procurement of personal protective equipment, rigorous employee education, patient triage and treatment protocol development and implementation. In addition, possible greater presence of cross- reactive adaptive T cell mediated immunity in healthcare workers vs. the general population may have contributed. Determining antibody prevalence in front-line workers, and duration of antibody presence may help stratify the workforce for risk, establish better health place policies and procedures, and potentially better mitigate transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded by Orange County Healthcare Agency and Hoag Hospital Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval was obtained for this study from Providence St. Joseph Health IRB (# 2020000337).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cannot be shared publicly because of possible hospital data access restrictions. However, upon acceptance of the manuscript, data will be available from the Hoag Center for Research and Education (contact via junko.hara{at}hoag.org) for researchers who meet the criteria for access to confidential data.